Get started
VENUS REMEDIES LTD.VENUS REMEDIES LTD.VENUS REMEDIES LTD.

VENUS REMEDIES LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

VENUSREM chart


Full chart

Key stats


Market capitalization
‪4.51 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
20.40
Basic EPS (TTM)
16.55 INR
Net income (FY)
‪284.91 M‬ INR
Revenue (FY)
‪5.91 B‬ INR
Shares float
‪7.39 M‬
Beta (1Y)
0.47

Employees


Employees (FY)
‪1.19 K‬
Change (1Y)
+189 +18.94%
Revenue / Employee (1Y)
‪4.98 M‬ INR
Net income / Employee (1Y)
‪240.02 K‬ INR

About VENUS REMEDIES LTD


Sector
Health Technology
CEO
Ashutosh Jain
Headquarters
Panchkula
Website
venusremedies.com
Founded
1989
ISIN
INE411B01019
FIGI
BBG000F5NYF5
Venus Remedies Ltd. engages in the manufacture and trade of pharmaceutical products. Its products include analgesic, analgesic and antipyretic, anti diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizer, hormone, iron supplement, neurology, oncology, pain management, respiratory, skin care, stress reliever, urology, vitamins/minerals/nutrients, and wound management. The company was founded by Pawan Chaudhary on September 15, 1989 and is headquartered in Panchkula, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

VENUSREM news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of VENUSREM is 338.75 INR — it has increased by 0.10% in the past 24 hours. Watch VENUS REMEDIES LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange VENUS REMEDIES LTD. stocks are traded under the ticker VENUSREM.
VENUSREM stock has risen by 5.83% compared to the previous week, the month change is a 5.56% rise, over the last year VENUS REMEDIES LTD. has showed a −13.46% decrease.
We've gathered analysts' opinions on VENUS REMEDIES LTD. future price: according to them, VENUSREM price has a max estimate of 399.00 INR and a min estimate of 399.00 INR. Watch VENUSREM chart and read a more detailed VENUS REMEDIES LTD. stock forecast: see what analysts think of VENUS REMEDIES LTD. and suggest that you do with its stocks.
VENUSREM reached its all-time high on Aug 9, 2021 with the price of 638.50 INR, and its all-time low was 3.85 INR and was reached on Mar 23, 2004. View more price dynamics on VENUSREM chart.
See other stocks reaching their highest and lowest prices.
VENUSREM stock is 2.25% volatile and has beta coefficient of 0.47. Track VENUS REMEDIES LTD. stock price on the chart and check out the list of the most volatile stocks — is VENUS REMEDIES LTD. there?
Today VENUS REMEDIES LTD. has the market capitalization of ‪4.52 B‬, it has increased by 4.53% over the last week.
Yes, you can track VENUS REMEDIES LTD. financials in yearly and quarterly reports right on TradingView.
VENUSREM net income for the last quarter is ‪35.10 M‬ INR, while the quarter before that showed ‪12.20 M‬ INR of net income which accounts for 187.70% change. Track more VENUS REMEDIES LTD. financial stats to get the full picture.
No, VENUSREM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 12, 2024, the company has ‪1.19 K‬ employees. See our rating of the largest employees — is VENUS REMEDIES LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VENUS REMEDIES LTD. EBITDA is ‪476.90 M‬ INR, and current EBITDA margin is 8.78%. See more stats in VENUS REMEDIES LTD. financial statements.
Like other stocks, VENUSREM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VENUS REMEDIES LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VENUS REMEDIES LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VENUS REMEDIES LTD. stock shows the strong buy signal. See more of VENUS REMEDIES LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.